MiNK Therapeutics Inc. (NASDAQ: INKT)
$6.4150
-0.1850 ( -4.82% ) 42.7K
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Market Data
Open
$6.4150
Previous close
$6.6000
Volume
42.7K
Market cap
$26.16M
Day range
$6.2950 - $7.3200
52 week range
$4.5601 - $19.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| effect | Other | 1 | Aug 16, 2024 |
| corresp | Comment letters | 1 | Aug 15, 2024 |
| upload | Comment letters | 2 | Aug 15, 2024 |
| s-8 | Registration statements | 6 | Aug 13, 2024 |
| 8-k | 8K-related | 15 | Aug 13, 2024 |
| s-3 | Registration statements | 7 | Aug 13, 2024 |
| 10-q | Quarterly Reports | 52 | Aug 13, 2024 |
| 8-k | 8K-related | 11 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |